We are live on ! Find out more
HighTower Advisors

HighTower Advisors Portfolio holdings

AUM $94.2B
1-Year Est. Return 21.24%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$10.4B
AUM Growth
+$1.24B
Cap. Flow
+$859M
Cap. Flow %
8.22%
Top 10 Hldgs %
15%
Holding
2,232
New
303
Increased
1,040
Reduced
589
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 10.57%
2 Healthcare 9.74%
3 Financials 9.48%
4 Industrials 8.14%
5 Energy 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AG icon
1926
First Majestic Silver
AG
$8.05B
$41K ﹤0.01%
+5,097
New +$45.4K
DVN icon
1927
PUT
Devon Energy
DVN
$51.9B
$41K ﹤0.01%
97,000
-2,600
-3% -$114K
IWM icon
1928
CALL
iShares Russell 2000 ETF
IWM
$80.9B
$41K ﹤0.01%
+11,500
New +$1.57M
MUX icon
1929
McEwen Inc
MUX
$1.03B
$41K ﹤0.01%
+1,361
New +$49.1K
ROX
1930
DELISTED
Castle Brands, Inc.
ROX
$41K ﹤0.01%
26,500
+10,000
+61% +$9.21K
CIE
1931
DELISTED
Cobalt International Energy, Inc
CIE
$41K ﹤0.01%
5,049
ANF icon
1932
CALL
Abercrombie & Fitch
ANF
$4.17B
$40K ﹤0.01%
+29,300
New +$349K
EGO icon
1933
Eldorado Gold
EGO
$8.31B
$40K ﹤0.01%
2,366
+10
+0.4% +$168
IMUX icon
1934
Immunic
IMUX
$182M
$40K ﹤0.01%
25
VTGN icon
1935
VistaGen Therapeutics
VTGN
$9.29M
$39K ﹤0.01%
674
VIVS
1936
VivoSim Labs
VIVS
$1.46M
$37K ﹤0.01%
46
-21
-31% -$16.6K
CRDF icon
1937
Cardiff Oncology
CRDF
$64.3M
$36K ﹤0.01%
424
-1,041
-71% -$141K
RIGL icon
1938
Rigel Pharmaceuticals
RIGL
$680M
$33K ﹤0.01%
1,000
ATRS
1939
DELISTED
Antares Pharma, Inc.
ATRS
$33K ﹤0.01%
11,100
MACK
1940
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$33K ﹤0.01%
+1,373
New +$34.4K
AXP icon
1941
CALL
American Express
AXP
$223B
$32K ﹤0.01%
+10,500
New +$821K
BA icon
1942
CALL
Boeing
BA
$165B
$31K ﹤0.01%
+4,300
New +$732K
MVIS icon
1943
Microvision
MVIS
$88.2M
$29K ﹤0.01%
+11,279
New +$19.2K
NAK
1944
Northern Dynasty Minerals
NAK
$885M
$29K ﹤0.01%
+20,266
New +$41.6K
TOVX icon
1945
Theriva Biologics
TOVX
$10.2M
$29K ﹤0.01%
5
+1
+25% +$6.98K
EGIO
1946
DELISTED
Edgio, Inc. Common Stock
EGIO
$29K ﹤0.01%
284
ARNA
1947
DELISTED
Arena Pharmaceuticals Inc
ARNA
$29K ﹤0.01%
2,023
-50
-2% -$741
LIQT icon
1948
LiqTech
LIQT
$21.5M
$27K ﹤0.01%
2,178
DB icon
1949
CALL
Deutsche Bank
DB
$66.3B
$26K ﹤0.01%
12,500
+1,300
+12% +$22.5K
GSAT icon
1950
Globalstar
GSAT
$10.2B
$25K ﹤0.01%
+1,039
New +$23.3K

Similar funds

HighTower Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, HighTower Advisors held 2,232 positions worth $10.4B, up 14% from $9.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

HighTower Advisors deployed $859M of net new capital in Q1 2017, opening 303 new positions and adding to 1,040 existing holdings. Its largest new stake was Dorian LPG: 1,164,134 shares worth $12.3M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR Portfolio Aggregate Bond ETF, an estimated $16.6M trimmed.

  • HighTower Advisors's largest Q1 2017 buy was Dorian LPG: 1,164,134 shares worth $12.3M.
  • HighTower Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $55M increase.
  • HighTower Advisors's biggest Q1 2017 reduction was State Street SPDR Portfolio Aggregate Bond ETF, cutting an estimated $16.6M.
  • HighTower Advisors fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $13.5M.
  • HighTower Advisors's ten largest holdings make up 15% of its $10.4B portfolio in Q1 2017.
  • HighTower Advisors opened 303 new positions and closed 155 in Q1 2017.
  • HighTower Advisors's portfolio value rose 14% quarter-over-quarter to $10.4B.

Based on HighTower Advisors's 13F filing for Q1 2017, filed 16 May 2017.